Cargando…
PB2562: STUDY DESIGN OF THE AURORA TRIAL: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
Autores principales: | Levy, Cynthia, Anderson, Karl E., Balwani, Manisha, Bonkovsky, Herbert L., Dickey, Amy, Keel, Siobán, Mcguire, Brendan, Smith, Roy, Thapar, Manish, Wang, Bruce, Savage, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429793/ http://dx.doi.org/10.1097/01.HS9.0000976940.90434.6e |
Ejemplares similares
-
Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria
por: Dickey, Amy K., et al.
Publicado: (2020) -
P1498: INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
por: Ross, Gayle, et al.
Publicado: (2023) -
A pilot study of oral iron therapy in erythropoietic protoporphyria and X-linked protoporphyria
por: Balwani, Manisha, et al.
Publicado: (2022) -
Evaluating quality of life tools in North American patients with erythropoietic protoporphyria and X‐linked protoporphyria
por: Naik, Hetanshi, et al.
Publicado: (2019) -
How I treat erythropoietic protoporphyria and X-linked protoporphyria
por: Leaf, Rebecca Karp, et al.
Publicado: (2023)